, M15 : Non, non ! Parce qu'ils me connaissent mes patients ! Ils savent que je suis chiant (rires)... que c'est toujours mon leitmotiv. Donc, je veux dire... je n'arrête pas de les tanner ! Ils savent de toute façon que je vais toujours

, Ce qui fait que ça passe très bien, les gens en rigolent et puis au bout du compte il y a des gens, avec qui ça passe, il y a un message qui passe. I : Pour vous, ce dépistage peut-être complémentaire à la prévention contre le tabagisme ? M15 : Ah bien sûr ! Tout est... déjà, dès qu'on leur dit qu'il y a un risque de cancer du poumon, ça les interpelle. Je veux dire... bon même si ils le savent, J'introduis toujours ça dans la conversation d'une manière positive ! Et pas avec une sanction ! C'est toujours une... j'essaye toujours d'incorporer ça à ma conversation d'une manière positive

, De toute façon, tous les moyens sont bons ! (rires) Tout ce que je peux utiliser, je l'utilise ! (rires) I : Voyez-vous d'autre(s) chose(s) à ajouter ? M15 : Non ! Non ! Pfff Pour moi, c'est... je veux dire que c'est une bonne chose et puis bon, il faudrait pouvoir dépister tous les cancers ! Ça serait bien ! C'est le meilleur moyen de les traiter ! Mais pour le moment, on a encore des travaux à faire sur la question ! Mais c'est vrai que ça, c'était déjà une bonne chose ! Donc, là déjà, on a un moyen pas trop agressif pour dépister ! Bon après ! C'est un coût

F. Inca--les-cancers-en,

D. Sur,

, Cancer du poumon -Bilan initial : recommandation argumentées -Ref : RECOPOUM11 [Internet

W. D. Travis, H. Asamura, A. A. Bankier, M. B. Beasley, F. Detterbeck et al., The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer, vol.11, issue.8, pp.1204-1227, 2016.

A. J. Alberg, J. G. Ford, and J. M. Samet, Epidemiology of Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines, CHEST. 1 sept, vol.132, issue.3, pp.29-55, 2007.

M. Ezzati and A. D. Lopez, Estimates of global mortality attributable to smoking in 2000, Lancet Lond Engl. 13 sept, vol.362, issue.9387, pp.847-52, 2003.

M. M. Oken, W. G. Hocking, P. A. Kvale, G. L. Andriole, S. S. Buys et al., Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial, JAMA, vol.306, issue.17, pp.1865-73, 2011.

P. M. Marcus, E. J. Bergstralh, R. M. Fagerstrom, D. E. Williams, R. Fontana et al., Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up, J Natl Cancer Inst. 16 août, vol.92, issue.16, pp.1308-1324, 2000.

C. I. Henschke, D. F. Yankelevitz, D. M. Libby, M. W. Pasmantier, and J. P. Smith, Survival of patients with stage I lung cancer detected on CT screening, International Early Lung Cancer Action Program Investigators, vol.355, pp.1763-71, 2006.

Y. Toyoda, T. Nakayama, Y. Kusunoki, H. Iso, and T. Suzuki, Sensitivity and specificity of lung cancer screening using chest low-dose computed tomography, Br J Cancer. 20 mai, vol.98, issue.10, pp.1602-1609, 2008.

S. J. Swensen, J. R. Jett, T. E. Hartman, D. E. Midthun, J. A. Sloan et al., Lung cancer screening with CT: Mayo Clinic experience, Radiology. mars, vol.226, issue.3, pp.756-61, 2003.

, The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan

J. K. Gohagan, P. M. Marcus, R. M. Fagerstrom, P. F. Pinsky, B. S. Kramer et al., Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer, Lung Cancer Amst Neth. janv, vol.47, issue.1, pp.9-15, 2005.

T. Blanchon, J. Bréchot, P. A. Grenier, G. R. Ferretti, E. Lemarié et al., Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR). Lung Cancer Amst Neth, vol.58, pp.50-58, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00173095

, Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening | NEJM

D. Sur,

M. Infante, F. R. Lutman, S. Cavuto, G. Brambilla, G. Chiesa et al., Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial, Lung Cancer Amst Neth. mars, vol.59, issue.3, pp.355-63, 2008.

Z. Saghir, A. Dirksen, H. Ashraf, K. S. Bach, J. Brodersen et al., CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT, Thorax. avr, vol.67, issue.4, pp.296-301, 2012.

U. Pastorino, M. Rossi, V. Rosato, A. Marchianò, N. Sverzellati et al., Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial, Eur J Cancer Prev Off J Eur Cancer Prev Organ ECP. mai, vol.21, issue.3, pp.308-323, 2012.

J. K. Field, S. W. Duffy, D. R. Baldwin, K. E. Brain, A. Devaraj et al., The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer, Health Technol Assess Winch Engl, vol.20, issue.40, pp.1-146, 2016.

, Randomized Study on Early Detection of Lung Cancer with MSCT in Germany: Results of the First 3 Years of Follow-up After Randomization. -PubMed -NCBI

J. K. Field, R. A. Smith, D. R. Aberle, M. Oudkerk, D. R. Baldwin et al., International Association for the Study of Lung Cancer Computed Tomography Screening Workshop, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. janv, vol.7, issue.1, pp.10-19, 2011.

P. B. Bach, J. N. Mirkin, T. K. Oliver, C. G. Azzoli, D. A. Berry et al., Benefits and Harms of CT Screening for Lung Cancer: A Systematic Review, JAMA. 13 juin, vol.307, issue.22, pp.2418-2447, 2012.

M. T. Jaklitsch, F. L. Jacobson, J. Austin, J. K. Field, J. R. Jett et al., The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups, J Thorac Cardiovasc Surg. juill, vol.144, issue.1, pp.33-41, 2012.

, Final Recommendation Statement: Lung Cancer: Screening -US Preventive Services Task Force

D. Sur,

, CMS Adds Medicare Coverage for LDCT Screening for Lung Cancer in Certain Patients

, AJMC

D. Sur,

, ESMO Consensus Conference: Early stage non-small cell lung cancer consensus on diagnosis, treatment and follow-up | OncologyPRO

D. Sur,

, ESR/ERS white paper on lung cancer screening

D. Sur,

S. Couraud, A. B. Cortot, L. Greillier, V. Gounant, B. Mennecier et al., From randomized trials to the clinic: is it time to implement individual lung-cancer screening in clinical practice? A multidisciplinary statement from French experts on behalf of the french intergroup (IFCT) and the groupe d'Oncologie de langue française (GOLF), Ann Oncol. 1 mars, vol.24, issue.3, pp.586-97, 2013.

, Haute Autorité de Santé -Pertinence du dépistage du cancer broncho-pulmonaire en France -Point de situation sur les données disponibles -Analyse critique des études contrôlées randomisées

S. Portillo, Study Confirms CT Screening for Nodule Volume Management Reduces Lung Cancer Mortality by 26%

. Onco'zine, , p.19, 2018.

D. Sur,

. Dubois-c, Communiqué -Dépistage du cancer du poumon

D. Sur,

O. Leleu, M. Auquier, O. Carre, B. Chauffert, A. Dubreuil et al., Dépistage des cancers bronchopulmonaires par tomodensitométrie thoracique à faible dose dans la Somme, Rev Mal Respir. mars, vol.34, issue.3, pp.262-269, 2017.

S. Couraud, N. Girard, S. Erpeldinger, F. Gueyffier, G. Devouassoux et al., Physicians' Knowledge and Practice of Lung Cancer Screening: A Cross-Sectional Survey Comparing General Practitioners, Thoracic Oncologists, and Pulmonologists in France, Clin Lung Cancer. 1 sept, vol.14, issue.5, pp.574-80, 2013.

. Bop-bungener-martine, . François, and (. Gilles, Médecins généralistes et dépistage des cancers. Synthèse des résultats de l'enquête barométrique INCa/BVA septembre 2010 : Bib

C. Dubois and C. Attali, Motivations et réticences des médecins généralistes de l'Essonne à proposer les dépistages de masse organisés du cancer du sein et du cancer colo-rectal

F. Upec, , 2008.

, Dépistage du cancer du sein en médecine libérale : une enquête auprès des généralistes et des gynécologues de Rhône-Alpes -ScienceDirect

D. Sur,

J. A. Roth, L. Carter-harris, S. Brandzel, D. Buist, and K. J. Wernli, A qualitative study exploring patient motivations for screening for lung cancer, PloS One, vol.13, issue.7, p.196758, 2018.

I. Aubin-auger, A. Mercier, L. Baumann-coblentz, T. L. Trung, Y. Decorre et al., Identifier les obstacles au dépistage du cancer colorectal et envisager les moyens de les surmonter, vol.19, p.4

L. Exercer and . Revue-francophone-de-médecine-générale, exercer, la revue francophone de Médecine Générale

. Dépistage and . Roche,

D. Sur,

, Mammography screening in France: Results of EDIFICE study, Journal of Clinical Oncology, vol.24

, Perception du risque de cancer du poumon | Roche

D. Sur,

F. E. Mcronald, G. Yadegarfar, D. R. Baldwin, A. Devaraj, K. E. Brain et al., The UK Lung Screen (UKLS): demographic profile of first 88,897 approaches provides recommendations for population screening, Cancer Prev Res Phila Pa. mars, vol.7, issue.3, pp.362-71, 2014.

, Informed participation in a randomised controlled trial of computed tomography screening for lung cancer

D. Sur,

S. E. Smits, G. M. Mccutchan, J. A. Hanson, and K. E. Brain, Attitudes towards lung cancer screening in a population sample, Health Expect Int J Public Particip Health Care Health Policy. déc, vol.21, issue.6, pp.1150-1158, 2018.

S. A. Kovalchik, M. Tammemagi, C. D. Berg, N. E. Caporaso, T. L. Riley et al., Targeting of low-dose CT screening according to the risk of lung-cancer death, N Engl J Med. 18 juill, vol.369, issue.3, pp.245-54, 2013.

B. Milleron, V. Gounant, A. Khalil, and S. Couraud, , 2017.

D. Sur,

R. Yip, C. I. Henschke, D. F. Yankelevitz, and J. P. Smith, CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases, Radiology. nov, vol.273, issue.2, pp.591-597, 2014.

U. Yousaf-khan, C. Van-der-aalst, P. A. De-jong, M. Heuvelmans, E. Scholten et al., Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval, Thorax. janv, vol.72, issue.1, pp.48-56, 2017.

N. Hasan, R. Kumar, and M. S. Kavuru, Lung cancer screening beyond low-dose computed tomography: the role of novel biomarkers, Lung. oct, vol.192, issue.5, pp.639-687, 2014.

M. Wielscher, K. Vierlinger, U. Kegler, R. Ziesche, A. Gsur et al., Diagnostic Performance of Plasma DNA Methylation Profiles in Lung Cancer, Pulmonary Fibrosis and COPD, EBioMedicine. août, vol.2, issue.8, pp.929-965, 2015.

J. R. Jett, L. J. Peek, L. Fredericks, W. Jewell, W. W. Pingleton et al., Audit of the autoantibody test, EarlyCDT®-lung, in 1600 patients: an evaluation of its performance in routine clinical practice, Lung Cancer Amst Neth. janv, vol.83, issue.1, pp.51-56, 2014.

H. Casillas, C. E. , F. Fernández, J. M. , P. Camberos et al., Current status of circulating protein biomarkers to aid the early detection of lung cancer, Future Oncol Lond Engl. juin, vol.10, issue.8, pp.1501-1514, 2014.

, Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study

D. Sur,

, Circulating Tumor Cells in Lung Cancer Screening -Full Text View -ClinicalTrials

D. Sur,

M. Ilie, V. Hofman, E. Long-mira, E. Selva, J. Vignaud et al., « Sentinel » circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease, PloS One, vol.9, issue.10, p.111597, 2014.

, Imagerie médicale computationnelle (radiomique) et potentiel en immuno-oncologie -ScienceDirect

D. Sur,

C. Y. Kong, J. M. Lee, P. M. Mcmahon, K. P. Lowry, Z. B. Omer et al., Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections, Radiology. mars, vol.262, issue.3, pp.977-84, 2012.

M. Ohana, C. Ludes, M. Schaal, E. Meyer, M. Jeung et al., Quel avenir pour la radiographie thoracique face au scanner ultra-low dose ? /data/revues/07618417/v73i1/S0761841716301183, 2017.

D. Sur,

S. W. Lee, Y. Kim, S. S. Shim, J. K. Lee, S. J. Lee et al., Image quality assessment of ultra low-dose chest CT using sinogram-affirmed iterative reconstruction, Eur Radiol. avr, vol.24, issue.4, pp.817-843, 2014.

H. Kim, M. Park, C. , C. , H. Lee et al., Impact of radiation dose and iterative reconstruction on pulmonary nodule measurements at chest CT: a phantom study, Diagn Interv Radiol, vol.21, issue.6, pp.459-65, 2015.

M. Zhang, W. Qi, Y. Sun, Y. Jiang, X. Liu et al., Screening for lung cancer using submillisievert chest CT with iterative reconstruction algorithm: image quality and nodule detectability, Br J Radiol. oct, vol.91, 1090.

Y. Nagatani, M. Takahashi, K. Murata, M. Ikeda, T. Yamashiro et al., Lung nodule detection performance in five observers on computed tomography (CT) with adaptive 108 iterative dose reduction using three-dimensional processing (AIDR 3D) in a Japanese multicenter study: Comparison between ultra-low-dose CT and low-dose CT by receiveroperating characteristic analysis, Eur J Radiol. juill, vol.84, issue.7, pp.1401-1413, 2015.

H. J. Yoon, M. J. Chung, H. S. Hwang, J. W. Moon, and K. S. Lee, Adaptive Statistical Iterative Reconstruction-Applied Ultra-Low-Dose CT with Radiography-Comparable Radiation Dose: Usefulness for Lung Nodule Detection, Korean J Radiol, vol.16, issue.5, pp.1132-1173, 2015.

C. I. Henschke, D. F. Yankelevitz, R. Yip, A. P. Reeves, A. Farooqi et al., Lung cancers diagnosed at annual CT screening: volume doubling times, Radiology. mai, vol.263, issue.2, pp.578-83, 2012.

E. F. Patz, P. Pinsky, C. Gatsonis, J. D. Sicks, B. S. Kramer et al., Overdiagnosis in low-dose computed tomography screening for lung cancer, JAMA Intern Med. 1 févr, vol.174, issue.2, pp.269-74, 2014.

, Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial

B. Pyenson and G. Dieguez, 2016 reflections on the favorable cost-benefit of lung cancer screening, Ann Transl Med. avr, vol.4, issue.8, p.155, 2016.

, Modélisation de l'impact économique d'un dépistage organisé du cancer du poumon en France -ScienceDirect, p.17, 2018.

I. F. Gareen, F. Duan, E. M. Greco, B. S. Snyder, P. M. Boiselle et al., Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial, Cancer, vol.120, issue.21, pp.3401-3410, 2014.

, Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON), p.17, 2018.

D. Sur,

, Long-term effects of lung cancer computed tomography screening on health-related quality of life: the NELSON trial

D. Sur,

M. Carbonell, Dépistage du cancer du poumon en médecine générale, 2012.

H. Ashraf, Z. Saghir, A. Dirksen, J. H. Pedersen, L. H. Thomsen et al., Smoking habits in the randomised Danish Lung Cancer Screening Trial with low-dose CT: final results after a 5-year screening programme, Thorax. juin, vol.69, issue.6, pp.574-583, 2014.

S. A. Barry, M. C. Tammemagi, S. Penek, E. C. Kassan, C. S. Dorfman et al., Predictors of adverse smoking outcomes in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, J Natl Cancer Inst, vol.104, issue.21, pp.1647-59, 2012.

L. Shi and M. Y. Iguchi, « Risk homeostasis »or « teachable moment »? the interaction between smoking behavior and lung cancer screening in the Mayo Lung Project, Tob Induc Dis, vol.24, 2011.

L. S. Cox, M. M. Clark, J. R. Jett, C. A. Patten, D. R. Schroeder et al., Change in smoking status after spiral chest computed tomography scan screening, Cancer. 1 déc, vol.98, issue.11, pp.2495-501, 2003.

M. A. Clark, J. J. Gorelick, J. D. Sicks, E. R. Park, A. L. Graham et al., The Relations Between False Positive and Negative Screens and Smoking Cessation and Relapse in the National Lung Screening Trial: Implications for Public Health, Nicotine Tob Res Off J Soc Res Nicotine Tob. janv, vol.18, issue.1, pp.17-24, 2016.

, Impact of lung cancer screening results on smoking cessation

D. Sur,

C. Rampinelli and M. Minotti, Improving CT screening for lung cancer with a highly predictive risk model, Ann Transl Med [Internet]. avr, vol.6, issue.7, 2018.

D. Sur,

M. C. Tammemägi, H. A. Katki, W. G. Hocking, T. R. Church, N. Caporaso et al., Selection criteria for lung-cancer screening, N Engl J Med. 21 févr, vol.368, issue.8, pp.728-764, 2013.

M. C. Tammemägi, T. R. Church, W. G. Hocking, G. A. Silvestri, P. A. Kvale et al., Evaluation of the Lung Cancer Risks at Which to Screen Ever-and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts, PLOS Med. 2 déc, vol.11, issue.12, p.1001764, 2014.

M. C. Tammemagi, H. Schmidt, S. Martel, A. Mcwilliams, J. R. Goffin et al., Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study, Lancet Oncol, vol.18, issue.11, pp.1523-1554, 2017.

, Dépistage du cancer bronchique en 2017 : mieux cibler la population et prendre en charge les nodules pulmonaires : Lung cancer screening in 2017: for a better focus on the population and management of pulmonary nodules -EM|consulte

D. Sur,

S. Schütte, D. Dietrich, X. Montet, and A. Flahault, Participation in lung cancer screening programs: are there gender and social differences? A systematic review, Public Health Rev, vol.39, p.23, 2018.

, Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study, p.17, 2018.

P. Souquet, I. Durand-zaleski, C. Chouaid, D. Debieuvre, A. Scherpereel et al., Diagnostic de cancer du poumon à un stade avancé : déterminants socioéconomiques et accès aux soins primaires et secondaires (étude Territoire), Rev Mal Respir. 1 janv, vol.34, pp.8-9, 2017.